Doses (mGy/MBq) from Combined Sources (Injected Breast + Total Body) to Adult Nonpregnant Female Models
| Organ | Reference model | MSKCC model | MSKCC childbearing model |
|---|---|---|---|
| Adrenals | 1.95E−03 | 1.76E−03 | 1.83E−03 |
| Brain | 1.50E−04 | 1.35E−04 | 1.40E−04 |
| Injected breast | 8.04E−01 | 2.97E−01 | 4.04E−01 |
| Gallbladder wall | 1.46E−03 | 1.32E−03 | 1.36E−03 |
| LLI wall | 1.80E−04 | 1.62E−04 | 1.68E−04 |
| Small intestine | 3.69E−04 | 3.33E−04 | 3.45E−04 |
| Stomach wall | 2.55E−03 | 2.31E−03 | 2.40E−03 |
| ULI wall | 5.38E−04 | 4.87E−04 | 5.05E−04 |
| Heart wall | 1.05E−02 | 9.49E−03 | 9.84E−03 |
| Kidneys | 8.30E−04 | 7.51E−04 | 7.79E−04 |
| Liver | 2.83E−03 | 2.56E−03 | 2.66E−03 |
| Lungs | 7.90E−03 | 7.16E−03 | 7.42E−03 |
| Muscle | 1.74E−03 | 1.57E−03 | 1.63E−03 |
| Ovaries | 1.79E−04 | 1.62E−04 | 1.68E−04 |
| Pancreas | 2.41E−03 | 2.18E−03 | 2.26E−03 |
| Red marrow | 1.90E−03 | 1.71E−03 | 1.78E−03 |
| Osteogenic cells | 3.11E−03 | 2.81E−03 | 2.91E−03 |
| Skin | 2.82E−03 | 2.56E−03 | 2.65E−03 |
| Spleen | 1.67E−03 | 1.51E−03 | 1.57E−03 |
| Thymus | 9.99E−03 | 9.05E−03 | 9.38E−03 |
| Thyroid | 1.27E−03 | 1.15E−03 | 1.20E−03 |
| Bladder wall | 1.46E−04 | 1.32E−04 | 1.37E−04 |
| Uterus | 1.88E−04 | 1.70E−04 | 1.77E−04 |
| Fetus | 0.00E+00 | 0.00E+00 | 0.00E+00 |
| Placenta | 0.00E+00 | 0.00E+00 | 0.00E+00 |
| Total body | 4.11E−03 | 3.67E−03 | 3.83E−03 |
| Effective dose (mSv/MBq) | 2.47E−02 | 9.90E−03 | 1.31E−02 |